(NYSE: PEN) Penumbra's forecast annual revenue growth rate of 17.3% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.7%, and it is also forecast to beat the US market's average forecast revenue growth rate of 9.39%.
Penumbra's revenue in 2024 is $1,058,522,000.On average, 7 Wall Street analysts forecast PEN's revenue for 2024 to be $48,117,317,757, with the lowest PEN revenue forecast at $47,919,000,208, and the highest PEN revenue forecast at $48,430,275,543. On average, 7 Wall Street analysts forecast PEN's revenue for 2025 to be $56,187,262,880, with the lowest PEN revenue forecast at $54,863,442,928, and the highest PEN revenue forecast at $56,948,176,816.
In 2026, PEN is forecast to generate $64,830,099,564 in revenue, with the lowest revenue forecast at $62,184,781,879 and the highest revenue forecast at $67,893,571,581.